Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Mar;81(3):738–744. doi: 10.1172/JCI113379

Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.

W B Rizzo 1, A L Dammann 1, D A Craft 1
PMCID: PMC442521  PMID: 3343337

Abstract

Lipid metabolism was studied in cultured skin fibroblasts from patients with the inherited disorder, Sjögren-Larsson syndrome (SLS). Intact SLS fibroblasts incubated in the presence of [1-14C]palmitate accumulated more radioactive hexadecanol than did normal cells, whereas incorporation of radioactivity into other cellular lipids was unaltered. The hexadecanol content of SLS fibroblasts was abnormally elevated. Hexadecanol accumulation was not due to increased fatty alcohol synthesis nor its deficient utilization for glycerol ether synthesis. The half-life of intracellular hexadecanol loaded into SLS fibroblasts was increased (70 min) compared with normal (15 min), and intact SLS fibroblasts showed impaired oxidation of [14C]-hexadecanol to fatty acid. Fatty alcohol:NAD+ oxidoreductase, the enzyme catalyzing this reaction, was deficient in SLS fibroblasts. Mean total activity in SLS fibroblasts (n = 5) was 13% of that in normal fibroblasts, and palmitoyl CoA-inhibitable activity was 1% of normal. Fibroblasts from two obligate SLS heterozygotes had enzyme activities intermediate between that in normal fibroblasts and individuals with SLS. These results suggest that the primary defect in SLS is deficiency of fatty alcohol:NAD+ oxidoreductase. SLS represents the first inherited disorder in man associated with an isolated abnormality in fatty alcohol metabolism.

Full text

PDF
738

Images in this article

740Image
on p.740

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angelini C., Philippart M., Borrone C., Bresolin N., Cantini M., Lucke S. Multisystem triglyceride storage disorder with impaired long-chain fatty acid oxidation. Ann Neurol. 1980 Jan;7(1):5–10. doi: 10.1002/ana.410070104. [DOI] [PubMed] [Google Scholar]
  2. Austin J., Armstrong D., Shearer L. Metachromatic form of diffuse cerebral sclerosis. V. The nature and significance of low sulfatase activity: a controlled study of brain, liver and kidney in four patients with metachromatic leukodystrophy (MLD). Arch Neurol. 1965 Dec;13(6):593–614. doi: 10.1001/archneur.1965.00470060029003. [DOI] [PubMed] [Google Scholar]
  3. Avigan J., Campbell B. D., Yost D. A., Hernell O., Holmgren G., Jagell S. F. Sjögren-Larsson syndrome: delta 5-and delta 6-fatty acid desaturases in skin fibroblasts. Neurology. 1985 Mar;35(3):401–403. doi: 10.1212/wnl.35.3.401. [DOI] [PubMed] [Google Scholar]
  4. Buxman M. M., Goodkin P. E., Fahrenbach W. H., Dimond R. L. Harlequin ichthyosis with epidermal lipid abnormality. Arch Dermatol. 1979 Feb;115(2):189–193. [PubMed] [Google Scholar]
  5. Chanarin I., Patel A., Slavin G., Wills E. J., Andrews T. M., Stewart G. Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J. 1975 Mar 8;1(5957):553–555. doi: 10.1136/bmj.1.5957.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  7. Guilleminault C. G., Harpey J. P., Lafourcade J. Sjögren-Larsson syndrome. Report of two cases in twins. Neurology. 1973 Apr;23(4):367–373. doi: 10.1212/wnl.23.4.367. [DOI] [PubMed] [Google Scholar]
  8. Hernell O., Holmgren G., Jagell S. F., Johnson S. B., Holman R. T. Suspected faulty essential fatty acid metabolism in Sjögren-Larsson syndrome. Pediatr Res. 1982 Jan;16(1):45–49. doi: 10.1203/00006450-198201001-00009. [DOI] [PubMed] [Google Scholar]
  9. Holmgren G., Jagell S., Seeman H., Steen G. Urinary amino acids and organic acids in the Sjögren-Larsson syndrome. Clin Genet. 1981 Jul;20(1):64–66. doi: 10.1111/j.1399-0004.1981.tb01809.x. [DOI] [PubMed] [Google Scholar]
  10. Hooft C., Kriekemans J., van Acker K., Devos E., Traen S., Verdonk G. Sjögren-Larsson syndrome with exudative enteropathy. Influence of medium-chain triclycerides on the symptomatology. Helv Paediatr Acta. 1967 Oct;22(5):447–458. [PubMed] [Google Scholar]
  11. Horrocks L. A. The alk-1-enyl group content of mammalian myelin phosphoglycerides by quantitative two-dimensional thin-layer chromatography. J Lipid Res. 1968 Jul;9(4):469–472. [PubMed] [Google Scholar]
  12. Jagell S., Gustavson K. H., Holmgren G. Sjögren-Larsson syndrome in Sweden. A clinical, genetic and epidemiological study. Clin Genet. 1981 Apr;19(4):233–256. doi: 10.1111/j.1399-0004.1981.tb00704.x. [DOI] [PubMed] [Google Scholar]
  13. KLENK E., KAHIKE W. UBER DAS VORKOMMEN DER 3.7.11.15-TETRAMETHYL-HEXADECANSAEURE (PHYTANSAEURE) IN DEN CHOLESTERINESTERN UND ANDEREN LIPOIDFRAKTIONEN DER ORGANE BEI EINEM KRANKHEITSFALL UN- BEKANNTER GENESE (VERDACHT AUF HEREDOPATHIA ATACTICA POLYNEURITIFORMIS. Hoppe Seylers Z Physiol Chem. 1963;333:133–139. doi: 10.1515/bchm2.1963.333.1.133. [DOI] [PubMed] [Google Scholar]
  14. Krisans S. K., Mortensen R. M., Lazarow P. B. Acyl-CoA synthetase in rat liver peroxisomes. Computer-assisted analysis of cell fractionation experiments. J Biol Chem. 1980 Oct 25;255(20):9599–9607. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. Lee T. Characterization of fatty alcohol:NAD+ oxidoreductase from rat liver. J Biol Chem. 1979 Apr 25;254(8):2892–2896. [PubMed] [Google Scholar]
  17. Miranda A., DiMauro S., Eastwood A., Hays A., Johnson W. G., Olarte M., Whitlock R., Mayeux R., Rowland L. P. Lipid storage myopathy, ichthyosis, and steatorrhea. Muscle Nerve. 1979 Jan-Feb;2(1):1–13. doi: 10.1002/mus.880020102. [DOI] [PubMed] [Google Scholar]
  18. Riendeau D., Meighen E. Enzymatic reduction of fatty acids and acyl-CoAs to long chain aldehydes and alcohols. Experientia. 1985 Jun 15;41(6):707–713. doi: 10.1007/BF02012564. [DOI] [PubMed] [Google Scholar]
  19. Rizzo W. B., Craft D. A., Dammann A. L., Phillips M. W. Fatty alcohol metabolism in cultured human fibroblasts. Evidence for a fatty alcohol cycle. J Biol Chem. 1987 Dec 25;262(36):17412–17419. [PubMed] [Google Scholar]
  20. SJOGREN T., LARSSON T. Oligophrenia in combination with congenital ichthyosis and spastic disorders; a clinical and genetic study. Acta Psychiatr Neurol Scand Suppl. 1957;113:1–112. [PubMed] [Google Scholar]
  21. Sylvester P. E. Pathological findings in Sjögren-Larsson syndrome. J Ment Defic Res. 1969 Dec;13(4):267–275. doi: 10.1111/j.1365-2788.1969.tb01091.x. [DOI] [PubMed] [Google Scholar]
  22. Theile U. Sjögren-Larsson syndrome. Oligophrenia--ichthyosis--di-tetraplegia. Humangenetik. 1974 May 17;22(2):91–118. [PubMed] [Google Scholar]
  23. Webster D., France J. T., Shapiro L. J., Weiss R. X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet. 1978 Jan 14;1(8055):70–72. doi: 10.1016/s0140-6736(78)90005-3. [DOI] [PubMed] [Google Scholar]
  24. Williams C. D., Avigan J. In vitro effects of serum proteins and lipids on lipid synthesis in human skin fibroblasts and leukocytes grown in culture. Biochim Biophys Acta. 1972 Mar 23;260(3):413–423. doi: 10.1016/0005-2760(72)90056-2. [DOI] [PubMed] [Google Scholar]
  25. Williams M. L., Elias P. M. Elevated n-alkanes in congenital ichthyosiform erythroderma. Phenotypic differentiation of two types of autosomal recessive ichthyosis. J Clin Invest. 1984 Jul;74(1):296–300. doi: 10.1172/JCI111415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Williams M. L., Elias P. M. Stratum corneum lipids in disorders of cornification: increased cholesterol sulfate content of stratum corneum in recessive x-linked ichthyosis. J Clin Invest. 1981 Dec;68(6):1404–1410. doi: 10.1172/JCI110391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Williams M. L., Koch T. K., O'Donnell J. J., Frost P. H., Epstein L. B., Grizzard W. S., Epstein C. J. Ichthyosis and neutral lipid storage disease. Am J Med Genet. 1985 Apr;20(4):711–726. doi: 10.1002/ajmg.1320200417. [DOI] [PubMed] [Google Scholar]
  28. Yao J. K., Rastetter G. M. Microanalysis of complex tissue lipids by high-performance thin-layer chromatography. Anal Biochem. 1985 Oct;150(1):111–116. doi: 10.1016/0003-2697(85)90447-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES